Metaphore Biotechnologies and Flagship Pioneering have entered a research collaboration with Novo Nordisk to develop up to two next-generation therapeutics for obesity management.   The collaboration is signed under the broader strategic partnership between Novo Nordisk and Flagship Pioneering to develop a portfolio of novel treatment approaches for cardiometabolic and rare diseases. Pioneering Medicines, Flagship’s in-house drug development and partnerships unit, is responsible for lead...